Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2024-10-01 (globenewswire.com)
Nxera Pharma Appoints Experienced Commercial R&D Executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan
Dr. Sugita – formerly Vice President, Head of R&D for Bristol Myers Squibb in Japan – brings nearly 20 years’ experience in R&D and commercial...
Read more
2024-09-17 (newscast.jp)
Global medical contract research organization market expected to reach USD 80.45 billion by 2032: Key players and technological advances accelerating drug discovery
The global contract research organization (CRO) market remains steady at US$43.76 billion. According to recent market analysis, it is expected to grow to $80.45 billion in 10 years, at a compound annual growth rate (CAGR) of 7%.
Read more
2024-09-09 (openpr.com)
Contract Research Organization Market is estimated to reach US$ 170,427.41 million by 2031- IQVIA, Parexel & Syneos Health.
Press release - DataM Intelligence 4market Research LLP - Contract Research Organization Market is estimated to reach US$ 170,427.41 million by 2031- IQVIA, Parexel & Syneos Health. - published on openPR.com
Read more
2024-07-25 (masslawyersweekly.com)
Corporate – Veil
Where a defendant corporation has moved to dismiss a breach of contract claim, that motion should be allowed because the plaintiff’s allegations are not enough to meet the demanding requirements for piercing the corporate veil.
Read more
2024-02-13 (pharmatutor.org)
PAREXEL looking for Senior Regulatory Affairs Associate
PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a
Read more
2024-01-07 (pharmatutor.org)
PAREXEL hiring Senior Clinical Research Associate
PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a
Read more
2023-11-17 (yahoo.com)
Parexel Named “Best Contract Research Organization” at 19th Annual Scrip Awards
Company recognized with prestigious industry award by a distinguished panel of life science industry executivesDURHAM, N.C., Nov. 17, 2023( GLOBE NEWSWIRE) -- Parexel, one of the world’ s largest clinical research organizations( CROs) providing the full range of Phase I to IV clinical development
Read more
2022-06-09 (digitaljournal.com)
Contract Research Organization Services Market Brief Analysis of Top Leading Companies From 2022-2028: IQVIA, LabCorp, PAREXEL, ICON plc - Digital Journal
The Global Contract Research Organization Services Market Research Report 2022 provides information on request size, share, trends, growth,
Read more
(pe-insights.com)
Private equity majors circle $9bn-valued Parexel as Pamplona Capital mulls exit options | Private Equity Insights
Contract research firm Parexel is said to garner takeover interest from Private equity giant EQT and a consortium of three other buyout majors.
Read more